Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Appl Opt ; 62(26): 7083-7090, 2023 Sep 10.
Article in English | MEDLINE | ID: mdl-37707050

ABSTRACT

The laser swept-frequency interferometric ranging method is commonly used in the field of large-scale, high-precision, and non-cooperative measurements. However, this method requires the laser chirp curve to be a stable straight line. Nonlinearities in the chirp can cause broadening of the target spectrum, which affects the accuracy of the frequency extraction of the beat signal, resulting in increased ranging error. Herein, a linear regression laser swept-frequency interferometry method based on the non-uniform fast Fourier transform is proposed, which effectively suppresses the influence of frequency modulation nonlinearity on ranging accuracy.

2.
Neuropharmacology ; 229: 109476, 2023 05 15.
Article in English | MEDLINE | ID: mdl-36849038

ABSTRACT

Agmatine is an endogenous polyamine produced from l-arginine and degraded by agmatinase (AGMAT). Studies in humans and animals have shown that agmatine has neuroprotective, anxiolytic, and antidepressant-like actions. However, little is known about the role of AGMAT in the action of agmatine or in the pathophysiology of psychiatric disorders. Therefore, this study aimed to investigate the role of AGMAT in the pathophysiology of MDD. In this study, we observed that AGMAT expression increased in the ventral hippocampus rather than in the medial prefrontal cortex in the chronic restraint stress (CRS) animal model of depression. Furthermore, we found that AGMAT overexpression in the ventral hippocampus elicited depressive- and anxiety-like behaviors, whereas knockdown of AGMAT exhibited antidepressant and anxiolytic effects in CRS animals. Field and whole-cell recordings of hippocampal CA1 revealed that AGMAT blockage increased Schaffer collateral-CA1 excitatory synaptic transmission, which was expressed both pre- and post-synaptically and was probably due to the inhibition of AGMAT-expressing local interneurons. Therefore, our results suggest that dysregulation of AGMAT is involved in the pathophysiology of depression and is a potential target for designing more effective antidepressants with fewer adverse effects to offer a better therapy for depression.


Subject(s)
Agmatine , Anti-Anxiety Agents , Humans , Rats , Animals , Agmatine/pharmacology , Agmatine/therapeutic use , Agmatine/metabolism , Ureohydrolases/metabolism , Ureohydrolases/pharmacology , Anxiety/drug therapy , Anxiety/metabolism , Hippocampus , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Antidepressive Agents/metabolism , Anti-Anxiety Agents/pharmacology , Stress, Psychological/drug therapy , Stress, Psychological/metabolism , Depression/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...